Breaking Down Vir Biotechnology: 6 Analysts Share Their Views
Breaking Down Vir Biotechnology: 6 Analysts Share Their Views
解析vir biotechnology：6位分析師分享了他們的觀點
The standing of Vir Biotechnology among financial experts is revealed through an in-depth...In the latest quarter, 6 analysts provided ratings for Vir Biotechnology (NASDAQ:VIR), showcasing a mix of bullish and bearish perspectives.
在最新的一季度中，6名分析師提供了Vir Biotechnology（NASDAQ：VIR）的評級，展示了看好和看淡的觀點的混合。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $65.33, a high estimate of $110.00, and a low estimate of $15.00. Observing a 2.08% increase, the current average has risen from the previous average price target of $64.00.
分析師分析的12個月價格目標提供了洞察，平均目標爲65.33美元，高估目標爲110.00美元，低估目標爲15.00美元。當前平均價值從先前的平均價格目標64.00美元上升了2.08％。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
The standing of Vir Biotechnology among financial experts is revealed through an in-depth...
通過對最近的分析師行動進行深...
登入免費觀看全文
登入/註冊